Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Blue Wavelength Light-blocking Glasses in ADHD-Insomnia
Evening Use of Polarized Glasses Designed to Filter Out Blue Light in Attention Deficit Hyperactivity Disorder - Delayed Circadian Rhythm Disorder Patients
Status: Enrolling
Updated:  12/12/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Blue Wavelength Light-blocking Glasses in ADHD-Insomnia
Evening Use of Polarized Glasses Designed to Filter Out Blue Light in Attention Deficit Hyperactivity Disorder - Delayed Circadian Rhythm Disorder Patients
Status: Enrolling
Updated: 12/12/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy of Quetiapine for Pediatric Delirium
Efficacy of Quetiapine for Pediatric Delirium
Status: Enrolling
Updated:  12/12/2017
Columbia University Medical Center
mi
from
New York, NY
Efficacy of Quetiapine for Pediatric Delirium
Efficacy of Quetiapine for Pediatric Delirium
Status: Enrolling
Updated: 12/12/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy of Quetiapine for Pediatric Delirium
Efficacy of Quetiapine for Pediatric Delirium
Status: Enrolling
Updated:  12/12/2017
NY Prebyterian Hospital/Weill Cornell Medical Center
mi
from
New York, NY
Efficacy of Quetiapine for Pediatric Delirium
Efficacy of Quetiapine for Pediatric Delirium
Status: Enrolling
Updated: 12/12/2017
NY Prebyterian Hospital/Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Music-listening During Deep Brain Stimulation to Relieve Anxiety
The Effects of Music Listening on Intra-operative Anxiety in Patients Undergoing Awake Deep Brain Stimulation for Movement Disorders.
Status: Enrolling
Updated:  12/12/2017
Cleveland Clinic
mi
from
Cleveland, OH
Music-listening During Deep Brain Stimulation to Relieve Anxiety
The Effects of Music Listening on Intra-operative Anxiety in Patients Undergoing Awake Deep Brain Stimulation for Movement Disorders.
Status: Enrolling
Updated: 12/12/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Probiotics for Quality of Life in Autism Spectrum Disorders
Probiotics for Quality of Life in Autism Spectrum Disorders
Status: Enrolling
Updated:  12/12/2017
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Probiotics for Quality of Life in Autism Spectrum Disorders
Probiotics for Quality of Life in Autism Spectrum Disorders
Status: Enrolling
Updated: 12/12/2017
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Barrow Neurological Institute - St. Joseph's Hospital
mi
from
Phoenix, AZ
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Barrow Neurological Institute - St. Joseph's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University of California San Francisco-Fresno
mi
from
Fresno, CA
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University of California San Francisco-Fresno
mi
from
Fresno, CA
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
The University of California Irvine
mi
from
Orange, CA
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
The University of California Irvine
mi
from
Orange, CA
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University of California-Davis
mi
from
Sacramento, CA
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
California Pacific Medical Center
mi
from
San Francisco, CA
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Hospital for Special Care
mi
from
New Britain, CT
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Hospital for Special Care
mi
from
New Britain, CT
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University of Miami Miller School of Medicine
mi
from
Miami, FL
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University Of South Florida Medical Center
mi
from
Tampa, FL
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University Of South Florida Medical Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Emory University
mi
from
Atlanta, GA
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Northwestern University
mi
from
Chicago, IL
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Indiana University
mi
from
Indianapolis, IN
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University of Iowa
mi
from
Iowa City, IA
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University of Kansas Medical Center
mi
from
Kansas City, KA
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Massachusetts General Hospital
mi
from
Charlestown, MA
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Massachusetts General Hospital
mi
from
Charlestown, MA
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
St. Mary's Health Care
mi
from
Grand Rapids, MI
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
St. Mary's Health Care
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Hennepin County Medical Center
mi
from
Minneapolis, MN
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Neurology Associates PC
mi
from
Lincoln, NE
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Neurology Associates PC
mi
from
Lincoln, NE
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University of Nevada School of Medicine
mi
from
Las Vegas, NV
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University of Nevada School of Medicine
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Columbia University
mi
from
New York, NY
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Research Foundation of State University of New York
mi
from
Syracuse, NY
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Research Foundation of State University of New York
mi
from
Syracuse, NY
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Carolinas Medical Center
mi
from
Charlotte, NC
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Wake Forest University
mi
from
Winston-Salem, NC
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Ohio State University
mi
from
Columbus, OH
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Providence ALS Center
mi
from
Portland, OR
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Providence ALS Center
mi
from
Portland, OR
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Penn State Hershey Medical Center
mi
from
Hershey, PA
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Penn State Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
ALS Center at Penn
mi
from
Philadelphia, PA
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
ALS Center at Penn
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Drexel University College of Medicine
mi
from
Philadelphia, PA
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Drexel University College of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Texas Neurology, PA
mi
from
Dallas, TX
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Texas Neurology, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Methodist Neurological Institute
mi
from
Houston, TX
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Methodist Neurological Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University of Texas Health Sciences Center
mi
from
San Antonio, TX
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University of Texas Health Sciences Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University of Utah
mi
from
Salt Lake City, UT
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University of Virginia Health System
mi
from
Charlottesville, VA
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Univ of Washington
mi
from
Seattle, WA
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Prince of Wales Hospital
mi
from
Randwick,
Phase 3 Study of Dexpramipexole in ALS
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Prince of Wales Hospital
mi
from
Randwick,
Click here to add this to my saved trials
Structurally Reorganizing Motor Cortex in Stroke Patients Through Hebbian-type Stimulation
Structurally Reorganizing Motor Cortex in Stroke Patients Through Hebbian-type Stimulation
Status: Enrolling
Updated:  12/13/2017
Emory University School of Medicine
mi
from
Atlanta, GA
Structurally Reorganizing Motor Cortex in Stroke Patients Through Hebbian-type Stimulation
Structurally Reorganizing Motor Cortex in Stroke Patients Through Hebbian-type Stimulation
Status: Enrolling
Updated: 12/13/2017
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials